These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36159008)

  • 1. Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt
    Yao X; He S; Wei M; Qin JP
    World J Gastroenterol; 2022 Aug; 28(31):4467-4470. PubMed ID: 36159008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the medium-term curative effect of transjugular intrahepatic portosystemic shunt through jugular vein with covered Viatorr stent].
    Lin ZP; Zhao JB; Chen SL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):440-444. PubMed ID: 31357760
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial.
    Ma J; Luo J; Zhang W; Zhou Y; Zhang Z; Yang M; Zhuang Z; Ma L; Yu J; Zhou X; Yan Z
    Trials; 2023 May; 24(1):312. PubMed ID: 37149647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt].
    Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis.
    Zhou Y; Ma J; Ju S; Zhang Z; Zhang W; Yang M; Zhou X; Yan Z; Luo J
    Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1110-1116. PubMed ID: 33741800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational hemodynamic analysis for optimal stent position in the transjugular intrahepatic portosystemic shunt procedure.
    Yin K; Wang X; Zheng T
    J Biomech; 2022 Oct; 143():111303. PubMed ID: 36126502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases].
    Zhou H; Yao X; Tang SH; Xie M; Feng ZS; Qin JP
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):54-59. PubMed ID: 33541024
    [No Abstract]   [Full Text] [Related]  

  • 12. Do the stent blind insertion into the main portal vein (MPV) and stent diameter influence the surgical outcome of the transjugular intrahepatic portosystemic shunt (TIPS)?
    Jiang L; Han H; Yang J; Fang R; Xin Y; Chen Q; Yao J; Li Z
    Comput Biol Med; 2023 Sep; 164():107306. PubMed ID: 37542920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the comparative analysis of the efficacy of transmesenteric vein extrahepatic portosystemic shunt and transjugular intrahepatic portosystemic shunt in the treatment of cavernous transformation of portal vein].
    Zhu YD; Li WX; Cui MZ; Wang H; Yang HP; Zhai ST
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):90-95. PubMed ID: 36948855
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know?
    Patel RK; Chandel K; Tripathy TP; Mukund A
    Eur J Radiol; 2021 Nov; 144():109986. PubMed ID: 34619618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.
    Qi XS; Bai M; Yang ZP; Fan DM
    World J Gastroenterol; 2014 Jun; 20(21):6470-80. PubMed ID: 24914368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
    Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
    Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation Using Fluency Versus Viatorr Stent-Grafts: A Single-Centre Retrospective Study.
    Wu HM; Huang SQ; Wan YM; Li YH; Xu Y
    Cardiovasc Intervent Radiol; 2022 May; 45(5):552-562. PubMed ID: 35274174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.
    Andring B; Kalva SP; Sutphin P; Srinivasa R; Anene A; Burrell M; Xi Y; Pillai AK
    World J Gastroenterol; 2015 Jul; 21(26):8110-7. PubMed ID: 26185383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.
    Zhao JB; Feng C; Zhu QH; He XF; Li YH; Chen Y
    World J Gastroenterol; 2014 Feb; 20(6):1602-7. PubMed ID: 24587637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.